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Abstract 
Purpose: To examine the effect of crude Polycephalomyces nipponicus Cod-MK1201 mycelial extract 
on the viability and cell surface morphology of methicillin-susceptible Staphylococcus aureus (MSSA) 
and methicillin-resistant Staphylococcus aureus (MRSA). 
Methods: Time-kill assays were conducted by incubating test bacteria with the extract and sampling at 
selected time points within a 24 h period. The effects of the extract on MSSA and MRSA ultrastructure 
were determined using a scanning electron microscope (SEM). 
Results: Time-kill assay data indicate a bactericidal effect against both strains of staphylococci. The 
extracts were rapidly bactericidal at concentrations of 1 x MIC and 2 x MIC, achieving complete 
elimination of the test bacterial strains within 2 h. SEM micrographs of S. aureus taken after treatment 
with various concentrations of the extract revealed extensive morphological alterations to the cell 
surface of both MSSA and MRSA.  
Conclusion: The results confirm the antibacterial activity of P. nipponicus Cod-MK1201 mycelial 
extract.  Further research may allow this to be developed as an alternative therapy to alleviate S. aureus 
infection. 
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Staphylococcus aureus is a major human 
pathogen, causing pyogenic infections such as 
abscesses, and even fatal septicemia [1]. 
Methicillin-resistant S. aureus (MRSA) infections 
have become an important problem in both the 
hospital and community requiring vancomycin for 
effective clinical treatment [2,3].  Alarmingly, 
MRSA strains with reduced susceptibility to 
vancomycin are now also being reported [4,5].  
Moreover, there have been reports of MRSA 
resistant to chlorhexidine and other disinfectants 
commonly used for infection control and reducing 
the spread of MRSA in hospitals [6-8]. To 
overcome the problem of antibiotic resistance, 
alternative sources of bioactive compounds are 
being screened for possible development as the 
next generation of antibacterial therapies.  
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Medicinal mushrooms have been used as 
traditional remedies for infectious diseases in 
many tropical countries, and represent a natural 
source of antimicrobial agents [9]. Cordyceps is a 
genus of entomopathogenic fungi that are used 
in traditional Chinese medicine for various health 
effects including immunomodulatory, anticancer, 
antioxidant, anti-inflammatory and antimicrobial 
activities [10-13]. Recently, it was demonstrated 
that Cordyceps taii extracts have broad-spectrum 
activity against both bacteria and fungi [14]. Also, 
a protein isolated from the cultured mycelia of 
Cordyceps sinensis has been reported to have 
activity against the bacteria Staphylococcus 
aureus, Escherichia coli, Proteus vulgaris, , and 
Salmonella enterica serovar Typhi [15]. The 
methanol extract from Cordyceps militaris has 
strong antibacterial and antifungal activity too 
[10]. These findings indicate that many 
entomopathogenic fungi produce bioactive 
compounds effective against microbial 
pathogens. However, time-kill data and 
information on the morphological effects of these 
extracts on bacterial cells is limited.  
 
In a previous study, we isolated the 
entomopathogenic fungus Cod-MK1201 from a 
dead cicada nymph and found it to have potent 
antibacterial activity against both Gram-positive 
and Gram-negative bacteria [16]. The isolate was 
subsequently identified as Polycephalomyces 
nipponicus based on fungal morphology, three 
regions of ribosomal nuclear DNA (ITS, LSU, 
SSU), and four protein-coding regions (rpb1, 
ef1α, β-tubulin, ATP6) [17].  However, the 
bactericidal activity of the crude extract of this 
isolate has not yet been characterized in terms of 
the kinetics of bacterial death. Therefore, the aim 
of the present study was to evaluate the activity 
of Cod-MK1201 ethanol extract against Gram-
positive Staphylococcus aureus by the time-kill 
method.  The effect of the ethanol extract on 




Microorganisms and antibacterial agent 
 
Two reference strains of Staphylococcus aureus, 
methicillin-sensitive Staphylococcus aureus 
(MSSA) strain DMST 2933 and methicillin- 
resistant Staphylococcus aureus (MRSA) strain 
DMST 20651 were obtained from the medical 
microorganism collection at the Department of 
Medical Sciences Thailand (DMST), Ministry of 
Public Health, Thailand. These were used in 
assays evaluating the antibacterial activity of the 
extract.  
 
Preparation of mycelial extract of 
Polycephalomyces nipponicus Cod-MK1201 
 
Mycelial extracts were prepared as described 
previously by Sandgee et al [16]. Briefly, mycelial 
discs were cut and inoculated into 25 ml of 
induced medium, then incubated at 28 C with 
shaking.  After 20 days, the mycelium on the 
surface of the culture medium was collected, 
dried (50 C overnight), powdered, and stored in 
a screw cap tube.  Ethanol 50 % (v/v) was then 
added to the dried mycelium, and the mycelial 
suspension (100 mg/ml) was sonicated with a 
high Intensity Ultrasonic Processor (Model 
VCX750, Newtown, CT, USA). This step was 





Time-kill assays were performed as described by 
White et al [19] and Aiyegoro et al [20], with 
some modifications regarding the counting of 
viable cells. MICs were determined by broth 
microdilution assay as described by Sangdee et 
al [16].  The extract was incorporated into 0.9 mL 
Mueller Hinton broth (MHB) at concentrations of 
1.56 mg/mL (0.5 x MIC), 3.125 mg/mL (1 x MIC) 
and 6.25 mg/mL (2 x MIC). Test tubes of MHB 
without extract were used as growth controls. 
Overnight cultures of the bacterial strains at cell 
densities of approximately 1 x 108 CFU/mL were 
used to inoculate 0.1 mL volumes of both test 
and control tubes. The cultures were then 
incubated in a shaker at 37 C for 1, 2, 4, 6 and 
24 h. After each interval, ten-fold serial dilutions 
were prepared with phosphate buffered saline 
(PBS), and 0.1 mL samples were pipetted onto 
Mueller Hinton agar (MHA) plates in duplicate. 
Colony counts were performed after 18 h 
incubation at 37 C. Plates with 30–300 colonies 
were used for these counts, and the kill rate was 
determined by plotting log10 viable counts 
(CFU/mL) against time.  Bactericidal activity was 
defined as a ≥ 3 log10 decrease in CFU/mL of the 
initial microbial population, while bacteriostatic 
activity was defined as a 3 log10 decrease in 
CFU/mL. 
 
Scanning electron microscopy (SEM) 
 
Scanning electron microscopy was used to 
determine the antibacterial effect of the mycelial 
extract on S. aureus cells. Briefly, the test 
bacteria were cultured in MHB and incubated at 
37C with shaking for 3 h. The turbidities of the 
final inocula were adjusted to the 0.5 McFarland 
standards. One hundred microliters of each 
bacterial cell suspension was then added to 900 
µL of the mycelial extract (at concentrations of 
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0.5 x MIC, 1 x MIC or 2 x MIC) in MHB. 
Untreated cells were used as growth controls. 
The cultures were then incubated in a shaker at 
37C for 24 h.  Each sample was placed in a 
separate vial, and cells from each tube were 
harvested by centrifugation. A 2.5 % 
glutaraldehyde solution was used to prefix all 
samples overnight at 4 °C. Thereafter, the 
samples were rinsed 3 times with PBS, and post-
fixed in 1 % osmium tetroxide in the same buffer 
for an hour. This was followed by 4 further rinses 
with PBS. After fixation, a graded series of 
acetone was used to dehydrate the specimens 
with 100 % acetone being used for the final step. 
The specimens were then mounted and coated 
with gold before examination by scanning 





Time-kill profiles  
 
Time-kill assays allow antibacterial agents to be 
classified as bacteriostatic or bactericidal, and 
characterization of the relationship between 
agent concentration and activity over time.  The 
results obtained with the mycelial extract and two 
S. aureus strains (MSSA strain DMST 2933 and 
MRSA strain DMST 20651) are shown in Figure 




Figure 1: Time-kill profiles for S. aureus (MSSA) 
DMST 2933 (A) and S. aureus (MRSA) DMST 20651 
(B) in Mueller-Hinton broth during treatment with 1.56 
mg/mL (0.5 x MIC), 3.125 mg/mL (1 x MIC) and 6.25 
mg/mL (2 x MIC) crude P. nipponica Cod-MK1201 
mycelial extract. : untreated control;  : 0.5 x MIC;  
: 1 x MIC; X: 2 x MIC 
control group shows these bacteria were actively 
growing from 1 to 24 h.  After 24 h incubation 
with 0.5 x MIC (1.56 mg/mL) of the extract, a 3 
log10 CFU/mL reduction in viability of S. aureus 
DMST 2933 occurred (Figure 1A), indicating the 
extract is bactericidal against this strain of 
MSSA. Comparable results were not obtained 
with 0.5 x MIC extract and S. aureus DMST 
20651 (Figure 1B), indicating this concentration 
of extract is bacteriostatic against MRSA.  
 
At a concentration of 1 x MIC (3.125 mg/mL), 
however, the extract was bactericidal against 
both tested organisms by 24 h.  Also, increasing 
the concentration to 2 x MIC (6.25 mg/mL) 
resulted in bactericidal activity against MSSA by 
1 h (Figure 1A).  Complete elimination of both 
test strains was achieved by 2 h treatments with 
1 x MIC and 2 x MIC extract. These results 
indicate that bactericidal activity of the extract is 




Samples of P. nipponicus mycelial extract-
treated S. aureus were examined by SEM to 
detect any physical changes in appearance of 
the cells.  SEM micrographs of S. aureus after 24 
h treatment with various concentrations (0.5 x 
MIC, 1 x MIC and 2 x MIC) of the extract 
revealed considerable morphological alterations 
to both the MSSA and MRSA strains (Figure 2 
and Figure 3).  Figure 2 shows the SEM images 
of treated and untreated control samples of S. 
aureus (MSSA) DMST 2933. Untreated cells 
were intact, smooth, and of normal coccal 
morphology (Figure 2A).  The destructive effects 
of the extract on test bacteria can be seen in 
Figure 2B-D.  Bulges are present at the cell 
surface and debris is observed, much more so 
than in the untreated control cells.  
 
Characteristic morphological alterations 
observed in S. aureus (MRSA) DMST 20651 
treated with mycelial extract are shown in Figure 
3.  Exposure to 0.5 x MIC, 1 x MIC and 2 x MIC 
of the mycelial extract for 24 h led to damage of 
the cell wall (Figure 3B-3D), as indicated by 
bulging at the cell surface.  Untreated control 
cells, by comparison, had a smooth surface 
(Figure 3A).  When MRSA was treated with 6.25 
mg/mL (2 x MIC) of the extract, cell morphology 
and surface appearance were dramatically 
altered (Figure 3D).  Whilst the samples were not 
prepared in a quantitative manner, it is clear from 
the micrographs that the number of damaged 
cells in the treated vials greatly outnumbers 
those in the control vials. These results indicate 
that the active compound had some effect on the 
cytoplasmic membrane and cell wall of bacteria.   
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Figure 2: SEM micrographs of S. aureus (MSSA) DMST 2933 after 24 h incubation with crude P. nipponicus 
mycelial extract. (A) Untreated cells (control), and cells treated with (B) 0.5 x MIC (1.56 mg/mL), (C) 1 x MIC 
(3.125 mg/mL), and (D) 2 x MIC (6.25 mg/mL) extract.  Magnification, x 15,000 
 
 
Figure 3: SEM micrographs of S. aureus (MRSA) DMST 20651 after 24 h incubation with crude P. nipponicus 
mycelial extract. (A) Untreated cells (control), and cells treated with (B) 0.5 x MIC (1.56 mg/mL), (C) 1 x MIC 
(3.125 mg/mL), and (D) 2 x MIC (6.25 mg/mL) extract.  Magnification, x 15,000 
 
This could have been caused by an alteration in 
cytoplasmic membrane permeability, leading to 




Increases in the incidence of multidrug-resistant 
S. aureus infections have prompted renewed 
efforts to identify biologically active molecules 
from natural sources that might be useful 
antibacterial therapies.  Several Cordyceps 
species extracts, including those from C. sinensis 
[15], C. militaris [10], C. sobilifera [9], and C. taii 
[14], have been reported to have potent 
antibacterial activity against human pathogenic 
bacteria.  In a previous study, we demonstrated 
the antibacterial effects of an ethanolic mycelial 
extract of P. nipponicus Cod-MK1201 against 
MSSA and MRSA strains.  Because the MIC and 
MBC values of the extract were quite low (3.125 
mg/mL) [16], it was decided that further 
characterization would be useful.  Therefore, the 
present study determined the time-kill profiles 
and morphological effects of the extract against 
MSSA and MRSA.  The findings obtained 
represent the first published information on the 
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microbial death kinetics and possible mechanism 
of action of P. nipponicus mycelial extract against 
antibiotic -susceptible and -resistant strains of S. 
aureus. 
 
The time-kill assay is an important method for 
determining the potency of bioactive extracts, 
and determining whether these are bactericidal 
or bacteriostatic.  The present study analyzed 
bacterial viability over time during treatment with 
various concentrations of P. nipponicus mycelial 
extract.  At sub-inhibitory levels (0.5 x MIC), the 
extract had bactericidal activity against MSSA, 
and bacteriostatic activity against MRSA.  The 
mycelial extract at a concentration equal to 2 x 
MIC was rapidly bactericidal, achieving complete 
elimination of both test bacterial strains within 2 
h.  All of the time-kill data obtained with the P. 
nipponicus mycelial extract showed its 
antibacterial activity to be time - and 
concentration-dependent. This finding correlates 
with that of Okemo et al [21], who found that 
Ximenia caffra extracts kill S. aureus in both a 
time- and concentration-dependent manner. 
Also, extracts of the endophytic fungus 
Nigrospora sphaerica CL-OP30 are active 
against S. aureus in a time- and concentration-
dependent manner during the first 12 h of 
treatment [22]. 
 
In addition to the time-kill data obtained, the 
effect of the P. nipponicus mycelial extract (0.5 x 
MIC, 1 x MIC and 2 x MIC) on S. aureus 
morphology was determined by SEM.  
Perturbations to cell surface morphology could 
be detected when MSSA and MRSA were 
treated with various concentration of the mycelial 
extract.  Scanning electron microscopy images 
captured at 15,000x magnification clearly show 
cell surface and morphological changes such as 
bulges, surface disruption, and broken cells.  
These alterations may be due to phenolic or 
other bioactive compounds present in the 
mycelial extract affecting the cell wall and 
cytoplasmic membrane of S. aureus, thereby 
causing leakage of bacterial cell contents and 
eventual cell lysis [16,23].  Similar results have 
been described in a study where S. aureus cells 
were treated with Nigrospora sphaerica CL-OP30 
extract. The authors attributed the formation of 
cavities, surface alterations, and appearance of 
collapsed and shrunken cells to leakage of 
cytoplasmic contents [22].  Similar cell wall 
effects have been reported in S. aureus treated 




The results of this study reveal that P. nipponicus 
Cod-MK1201 mycelial extract exhibits significant 
in vitro antibacterial activity against 
staphylococci. These entomopathogenic fungi 
may therefore be suitable candidates for 
bioprospecting for antimicrobial drugs.  Further 
studies will be required to isolate and identify the 
bioactive compounds present in P. nipponicus 
Cod-MK1201, and determine whether they could 
be developed as novel drugs for the treatment of 
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